Since late 2022, the evolution of artificial intelligence (AI) has been Wall Street's hottest trend. The ability for software ...

AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Palantir (NASDAQ:PLTR) is a colossal winner that’s just found a way to keep winning in 2025. With shares up more than 37% in ...

AI-related stocks have delivered explosive gains for the past two and a half years. Nvidia (NASDAQ:NVDA) turned its GPUs into ...

Discover how Palantir Technologies Inc.'s strong AI adoption and DoD collaboration drive growth. Click for my PLTR earnings ...

Tech bull Daniel Ives has listed his top five picks for the second half of 2025, reiterating that the “golden age of tech” ...

Palantir's massive run-up is tied to its valuation increasing. Any stock in the market could double under the same circumstances that Palantir's did. Palantir (NASDAQ: PLTR) has been one of the ...

High Valuation Palantir Technologies (NASDAQ:PLTR) has solidified its status as a stock market juggernaut, claiming the title ...

The IBD Breakout Opportunities ETF BOUT from Innovator Capital Management tracks the IBD Breakout Stocks Index. As with other ...

The latest investor updates on stocks that are trending on Tuesday ...

Joining Nvidia and Palantir on IBD Leaderboard, Wheaton Precious Metals looks to strike gold with a new breakout.